Aprea Therapeutics Management
Management criteria checks 2/4
Aprea Therapeutics' CEO is Oren Gilad, appointed in Jan 2011, has a tenure of 13.42 years. total yearly compensation is $877.43K, comprised of 62.7% salary and 37.3% bonuses, including company stock and options. directly owns 5.9% of the company’s shares, worth $1.53M. The average tenure of the management team and the board of directors is 2.8 years and 3 years respectively.
Key information
Oren Gilad
Chief executive officer
US$877.4k
Total compensation
| CEO salary percentage | 62.7% |
| CEO tenure | 13.4yrs |
| CEO ownership | 5.9% |
| Management average tenure | 2.8yrs |
| Board average tenure | 3yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$13m |
| Dec 31 2023 | US$877k | US$550k | -US$14m |
| Sep 30 2023 | n/a | n/a | -US$13m |
| Jun 30 2023 | n/a | n/a | -US$14m |
| Mar 31 2023 | n/a | n/a | -US$109m |
| Dec 31 2022 | US$753k | US$324k | -US$113m |
Compensation vs Market: Oren's total compensation ($USD877.43K) is above average for companies of similar size in the US market ($USD665.80K).
Compensation vs Earnings: Oren's compensation has increased whilst the company is unprofitable.
CEO
Oren Gilad (56 yo)
13.4yrs
Tenure
US$877,430
Compensation
Dr. Oren Gilad, Ph.D. is Co-Founder of Aprea Therapeutics, Inc (formerly known as Atrin Pharmaceuticals LLC) since 2011 and serves as its Chief Executive Officer since July 2022. Dr. Gilad serves as Presid...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 13.4yrs | US$877.43k | 5.9% $ 1.5m | |
| Senior VP | 1.4yrs | US$941.36k | 0.12% $ 31.0k | |
| Head of Technology | 7.4yrs | no data | no data | |
| Senior VP & Chief Scientific Officer | 9.7yrs | no data | no data | |
| Senior Vice President of Corporate Development & Strategy | less than a year | no data | no data | |
| Head of Pharmacology Development | 6.4yrs | no data | no data | |
| Chief Business Advisor | 2.1yrs | no data | no data | |
| Chief Medical Officer | less than a year | no data | no data | |
| Controller | 2.8yrs | no data | no data |
2.8yrs
Average Tenure
60yo
Average Age
Experienced Management: APRE's management team is considered experienced (2.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 2.1yrs | US$877.43k | 5.9% $ 1.5m | |
| Independent Director | 9.4yrs | US$58.73k | 0.61% $ 158.3k | |
| Independent Director | 4.8yrs | US$86.23k | 0.14% $ 36.4k | |
| Independent Director | 2.1yrs | US$57.23k | 0.31% $ 80.9k | |
| Independent Director | 2.1yrs | US$53.23k | 3.85% $ 998.3k | |
| Scientific & Clinical Advisory Board Member | 5.4yrs | no data | no data | |
| Independent Chairperson of the Board | 4yrs | US$61.16k | 0.0097% $ 2.5k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 2.1yrs | US$62.73k | 0.0055% $ 1.4k | |
| Scientific & Clinical Advisory Board Member | no data | no data | no data | |
| Scientific & Clinical Advisory Board | no data | no data | no data | |
| Scientific & Clinical Advisory Board Member | no data | no data | no data |
3.0yrs
Average Tenure
64yo
Average Age
Experienced Board: APRE's board of directors are considered experienced (3 years average tenure).